Liposomal Amphotericin B (LAmB)

DRUG4 trials

Sponsors

Duke University, Istituto Giannina Gaslini, Institute of Tropical Medicine, Belgium, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine

Conditions

Cutaneous LeihmaniasisGraft vs Host DiseaseHematopoietic Stem Cell TransplantationInvasive Fungal DiseaseInvasive Fungal InfectionsNeutropeniaProphylaxisTalaromycosis

Phase 3

Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST)

Not yet recruitingNCT06525389

Duke UniversityTalaromycosis

Start: 2026-09-01End: 2031-09-01Target: 428Updated: 2026-08-27

Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)

Not yet recruitingNCT07463040

Institute of Tropical Medicine, BelgiumCutaneous Leihmaniasis

Start: 2027-01-01End: 2029-08-31Target: 900Updated: 2026-03-10

Unknown Phase

L-AmB_ Retrospective mUlticenter Study on Mycosis prOphylaxis

Enrolling by invitationNCT06640296

Istituto Giannina GasliniInvasive Fungal Disease, Invasive Fungal Infections, Prophylaxis

Start: 2023-12-12End: 2026-05-31Target: 120Updated: 2025-05-04

Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children

RecruitingNCT07725263

Haikou Affiliated Hospital of Central South University Xiangya School of MedicineGraft vs Host Disease, Hematopoietic Stem Cell Transplantation, Invasive Fungal Infections +2

Start: 2026-02-01End: 2027-03-31Target: 30Updated: 2026-07-24